<div id="readability-page-1"><p>01:25 PM EST, 02/27/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:</p><p>We reiterate our 12-month target of $785, 72.8x our 2027 EPS estimate, below AXON's avg. fwd P/E of 100.1x (during the trailing-twelve-month period) but above peers' avg. of 52.8x. Following the strong Q4 beat, we raise our EPS estimates: 2026 by $0.15 to $7.94 and 2027 by $0.84 to $10.78. AXON's fundamental strength is evident in its record bookings of $7.4B (+46% Y/Y) and future contracted bookings of $14.4B. The AI Era Plan generated $750M in bookings during its first full year, demonstrating strong customer adoption. Net revenue retention of 125% reflects expanding wallet share with existing customers. 2026 revenue guidance of 27%-30% growth and new 2028 targets ($6B revenue, 28% EBITDA margin) showcase confidence in the company's product roadmap, including Axon 911, Vehicle Intelligence, and Body Mini. Geographic and vertical expansion into corrections, enterprise, and international markets (which surpassed $1B in bookings) provides multiple growth vectors beyond core U.S. state and local law enforcement.</p> <p>MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</p></div>

AXUP

AXON

GUNZ

<p>CFRA 對 Axon Enterprise, Inc. 維持強烈買入的意見，重申 12 個月目標價為 785 美元。分析師將 2026 年的每股收益預期上調至 7.94 美元，2027 年的預期上調至 10.78 美元，此次調整是基於強勁的第四季度表現。Axon 報告了創紀錄的 74 億美元訂單，未來合同訂單總額為 144 億美元。公司預計 2026 年收入增長將達到 27%-30%，並設定了 2028 年的新目標，展現了對其產品路線圖和擴展新市場的信心</p>

研究警報：CFRA 維持對 Axon Enterprise, Inc.股票的強烈買入建議